peptide nanoparticle have recently emerged as a versatile tool for biomedical applications - peptide-mass-fingerprinting-software PNCs enable targeted delivery of imaging agents to cancer cells Peptide Nanoparticle: Revolutionizing Targeted Delivery and Biomedical Applications

peptide-mass-spec The field of nanotechnology has witnessed a significant surge in interest surrounding peptide nanoparticles (PNPs), a class of advanced materials that harness the unique properties of both peptides and nanoparticles. These conjugates are emerging as powerful tools for a wide array of biomedical applications, including targeted delivery of therapeutic agents, diagnostics, and even prevention strategies. Their ability to self-assemble into diverse nanostructures and their inherent biocompatibility make them particularly attractive for overcoming challenges in drug delivery and therapeutic efficacy作者：AN Shirazi·2025·被引用次数：3—Using peptides to cap and stabilize MNPshas emerged as a key strategy in drug delivery, offering enhanced control over nanoparticle size, ....

At its core, a peptide nanoparticle is formed by conjugating peptides to a nanoparticle core or through the self-assembly of peptide molecules themselves. This fusion of components allows for the creation of sophisticated systems that can exploit the specificity of peptides for targeting particular cells or tissues, while the nanoparticle component provides a stable platform for carrying payloads2024年12月9日—The primary function of peptide-loaded nanoparticles isto protect and transport peptides, ensuring their stability and effectiveness within the .... For instance, peptide-based nanoparticles can be formulated by mixing a cell-penetrating peptide (CPP) or a modified CPP with other components.Tissue-specific mRNA delivery and prime editing with ... This approach is crucial for enhancing the intracellular delivery of therapeutic molecules, a persistent hurdle in conventional drug delivery.

One of the most promising applications of peptide nanoparticles lies in their role as theranostic platforms.作者：CD Spicer·2018·被引用次数：516—Peptide- and protein-nanoparticle conjugateshave emerged as powerful tools for biomedical applications, enabling the treatment, diagnosis, and prevention ... By conjugating specific peptides to nanoparticles, researchers can achieve targeted delivery of imaging agents to cancer cells.作者：C Pigliacelli·2020·被引用次数：59—This feature article summarizes the different methodologies that have been developed to obtainself-assembled peptide–inorganic nanoparticle hybrid... This enables sensitive detection and monitoring of disease progression. Furthermore, peptide-nanoparticle conjugates (PNCs) have emerged as a versatile tool for biomedical applications, allowing for the treatment, diagnosis, and prevention of various diseases. The synergistic interplay between the targeting capabilities of peptides and the payload-carrying capacity of nanoparticles opens up new avenues for personalized medicine作者：C Pigliacelli·2020·被引用次数：59—This feature article summarizes the different methodologies that have been developed to obtainself-assembled peptide–inorganic nanoparticle hybrid....

The fabrication of peptide nanoparticles can be achieved through various methods, with controlling self-assembly within nanospace for peptide nanoparticle fabrication being a key area of research作者：W Jeong·2022·被引用次数：35—This study presents a novel surface platform that utilizeshierarchicallycontrolled multivalent binding of peptides.. Techniques like microfluidics are being explored for the formation of peptide-based nanoparticles using amino acids, offering precise control over size and morphology.Design and optimization of peptide nanoparticles - Springer Link The ability to self-assemble into macromolecule-sized nanopores of 2–10 nm diameter is a testament to the intricate structural control achievable with peptide-based designs. Moreover, research into self-assembled peptide–inorganic nanoparticle hybrid systems highlights the integration of inorganic materials with peptides to create multifunctional nanomaterials.

Beyond imaging and diagnostics, peptide nanoparticles are revolutionizing drug and gene delivery. Peptide-based nanoparticles for therapeutic nucleic acid delivery are being developed to overcome the limitations of traditional non-viral delivery systems.Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery For example, peptide-guided lipid nanoparticles are showing significant promise in enabling mRNA delivery to the neural retina, expanding the utility of LNP-mRNA therapies for inherited retinal diseases.Peptide/Nanoparticle Biointerfaces for Multistep Tandem ... This advancement signifies a leap forward in treating conditions previously considered intractable. Similarly, peptide-conjugated lipid nanoparticles are being investigated for their potential to facilitate mRNA delivery and gene editing, holding the promise to transform the current therapeutic landscapePeptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery. These non-viral peptide-based nanoparticles offer advantages such as lower immunogenicity and improved safety profiles compared to viral vectors.

The inherent properties of peptides, such as high biocompatibility, specificity, biodegradability, and minimal immunogenicity, make them ideal for targeted applications. Peptide-based nanoparticles leverage these qualities to enhance the efficacy and safety of therapeutic interventions. For instance, self-assembling peptide nanoparticles (SAPNs) are formed by single peptide chains that can adopt specific secondary structures, leading to well-defined nanostructures. These SAPNs are crucial for applications like drug delivery, where they can protect and transport therapeutic peptides, ensuring their stability and effectiveness within the body.

The versatility of peptide nanoparticles extends to other therapeutic modalities as well. Photothermal therapy, an alternative to traditional cancer treatments, can be enhanced by peptide-loaded nanoparticles. In these systems, a peptide on the nanoparticle surface becomes active under specific conditions, helping the nanoparticles efficiently enter cancer cells and deliver therapeutic effects. Furthermore, peptide-nanoparticle conjugates are being explored as promising platforms for biomedical applications such as targeting, sensing, and imaging. The generation of multifunctional nanoparticle catalysts using peptide-based ligands showcases the potential for these materials in advanced chemical and biological processes.

The development of peptide nanoparticles is an active and evolving field作者：TAPF Doll·2015·被引用次数：64—Ourself-assembling peptide nanoparticles (SAPNs) are formed by a single peptide chain that consists of two helical coiled-coil segments .... Research continues to focus on designing and optimizing these systems for enhanced performance and broader applicability. The ability to create hierarchically controlled structures and to achieve multivalent binding of peptides to nanoparticle surfaces are key advancements driving innovation.作者：P Boisguérin·2021·被引用次数：86—In this review, we attempt to cover the most important biophysical and biological aspects ofnon-viral peptide-based nanoparticles(PBNs) for therapeutic ... As our understanding of peptide self-assembly and nanoparticle engineering deepens, peptide nanoparticles are poised to play an increasingly vital role in the future of medicine, offering sophisticated solutions for drug delivery, diagnostics, and therapeutic interventions. The exploration of peptide-based inorganic nanoparticle hybrids further expands the design space, allowing for the creation of materials with tailored properties for specific applications. Ultimately, these nanoparticle compositions including one or more peptides represent a significant step towards more precise and effective healthcare solutions.